0001415889-24-010079.txt : 20240403
0001415889-24-010079.hdr.sgml : 20240403
20240403172015
ACCESSION NUMBER: 0001415889-24-010079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moat Ross
CENTRAL INDEX KEY: 0001857177
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 24820110
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-04032024_090405.xml
X0508
4
2024-04-01
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001857177
Moat Ross
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF COMMERCIAL OFFICER
0
Class A Common Share
2024-04-01
4
M
0
1612
A
16032
D
Class A Common Share
2024-04-01
4
F
0
880
19.70
D
15152
D
Restricted Share Unit
2024-04-01
4
M
0
1612
0
D
Class A Common Share
1612
4833
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2024-04-03